- Home
- REAX vs CRMD Comparison
REAX vs CRMD Comparison
Compare REAX & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | REAX | CRMD |
|---|---|---|
| Founded | 2018 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 790.0M | 876.7M |
| IPO Year | N/A | 2010 |
Fundamental Metrics
Financial Performance| Metric | REAX | CRMD |
|---|---|---|
| Price | $4.20 | $11.57 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 7 |
| Target Price | $6.33 | ★ $17.43 |
| AVG Volume (30 Days) | 1.2M | ★ 3.3M |
| Earning Date | 10-30-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 2.25 |
| Revenue | ★ $1,813,907,000.00 | $214,303,672.00 |
| Revenue This Year | $56.57 | $627.89 |
| Revenue Next Year | $21.77 | $40.95 |
| P/E Ratio | ★ N/A | $5.09 |
| Revenue Growth | 65.60 | ★ 1647.67 |
| 52 Week Low | $3.42 | $5.60 |
| 52 Week High | $5.65 | $17.43 |
Technical Indicators
Market Signals| Indicator | REAX | CRMD |
|---|---|---|
| Relative Strength Index (RSI) | 62.44 | 61.65 |
| Support Level | $3.92 | $10.90 |
| Resistance Level | $3.99 | $12.10 |
| Average True Range (ATR) | 0.15 | 0.50 |
| MACD | 0.04 | 0.23 |
| Stochastic Oscillator | 98.08 | 79.62 |
Price Performance
Historical ComparisonAbout REAX The Real Brokerage Inc.
The Real Brokerage Inc is a technology-powered real estate brokerage firm located in the United States and Canada. It has developed a proprietary transaction management and brokerage operations software called reZEN, which powers nearly all of its brokerage operations, enabling efficiency, automation, and flexibility by incorporating end-to-end transaction management, automated compliance and brokerage oversight, integrated payments and financial services, Leo CoPilot, and open API for customization. In addition, the company also offers mortgage brokering and title services. The company's operating segments are North American Brokerage, which derives key revenue, One Real Title, One Real Mortgage, and Real Wallet. Geographically, it derives key revenue from the United States.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.